GNCA stock plunges 97% to $0.0001 on NASDAQ 09 Jan 2026: key risk signal

GNCA stock dropped to $0.0001 intraday, down 97.44%, putting Genocea Biosciences, Inc. (GNCA) on the top losers list on NASDAQ in the United States. We track the move with volume of 30,268 shares versus a 50-day average of 80,568. This sharp fall follows Chapter 11 reorganization and thin liquidity, and it changes short-term risk and valuation dynamics for investors.